Rise Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87K | Buy |
785
+2
| +0.3% | +$222 | 0.03% | 170 |
|
|
2025
Q1 | $87.8K | Buy |
783
+16
| +2% | +$1.79K | 0.04% | 160 |
|
|
2024
Q4 | $70.9K | Sell |
767
-24
| -3% | -$2.22K | 0.03% | 176 |
|
|
2024
Q3 | $66.4K | Buy |
791
+37
| +5% | +$3.1K | 0.03% | 194 |
|
|
2024
Q2 | $51.7K | Buy |
754
+8
| +1% | +$549 | 0.03% | 232 |
|
|
2024
Q1 | $54.6K | Buy |
746
+203
| +37% | +$14.9K | 0.03% | 217 |
|
|
2023
Q4 | $44K | Buy |
543
+162
| +43% | +$13.1K | 0.03% | 172 |
|
|
2023
Q3 | $28.6K | Sell |
381
-44
| -10% | -$3.3K | 0.02% | 194 |
|
|
2023
Q2 | $32.7K | Sell |
425
-25
| -6% | -$1.92K | 0.03% | 191 |
|
|
2023
Q1 | $37.3K | Buy |
450
+8
| +2% | +$664 | 0.03% | 182 |
|
|
2022
Q4 | $38K | Buy |
442
+48
| +12% | +$4.12K | 0.03% | 177 |
|
|
2022
Q3 | $24K | Buy |
394
+4
| +1% | +$244 | 0.02% | 219 |
|
|
2022
Q2 | $24K | Buy |
390
+298
| +324% | +$18.3K | 0.02% | 212 |
|
|
2022
Q1 | $5K | Buy |
92
+1
| +1% | +$54 | ﹤0.01% | 421 |
|
|
2021
Q4 | $6.62K | Buy |
+91
| New | +$6.62K | 0.01% | 373 |
|